Загрузка...
Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections
The management of SARS-CoV-2 has not yet been clearly determined and is based on potential therapies evaluated during the SARS-CoV and MERS-CoV outbreaks. An emerging potential therapeutic approach currently being evaluated in numerous clinical trials is the remdesivir agent, which acts on COVID-19...
Сохранить в:
| Опубликовано в: : | J Infect Public Health |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039503/ https://ncbi.nlm.nih.gov/pubmed/33857725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2021.02.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|